Stock Research for EBS

Current Price

$50.0200


Latest Update: 2018-02-16 16:00:00

High
$ 50.0200
Low
$ 49.9600
Close
$ 49.9800
Volume
3841
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

EBS Stock Chart & Research Data

The EBS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EBS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EBS Due diligence Resources & Stock Charts

The EBS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EBS Detailed Price Forecast - CNN Money CNN View EBS Detailed Summary - Google Finance
Yahoo View EBS Detailed Summary - Yahoo! Finance Zacks View EBS Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View EBS Trends & Analysis - Trade-Ideas Barrons View EBS Major Holders - Barrons
NASDAQ View EBS Call Transcripts - NASDAQ Seeking View EBS Breaking News & Analysis - Seeking Alpha
Spotlight View EBS Annual Report - CompanySpotlight.com OTC Report View EBS OTC Short Report - OTCShortReport.com
TradeKing View EBS Fundamentals - TradeKing Charts View EBS SEC Filings - Bar Chart
WSJ View Historical Prices for EBS - The WSJ Morningstar View Performance/Total Return for EBS - Morningstar
MarketWatch View the Analyst Estimates for EBS - MarketWatch CNBC View the Earnings History for EBS - CNBC
StockMarketWatch View the EBS Earnings - StockMarketWatch MacroAxis View EBS Buy or Sell Recommendations - MacroAxis
Bullish View the EBS Bullish Patterns - American Bulls Short Pains View EBS Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View EBS Stock Mentions - StockTwits PennyStocks View EBS Stock Mentions - PennyStockTweets
Twitter View EBS Stock Mentions - Twitter Invest Hub View EBS Investment Forum News - Investor Hub
Yahoo View EBS Stock Mentions - Yahoo! Message Board Seeking Alpha View EBS Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for EBS - SECform4.com Insider Cow View Insider Transactions for EBS - Insider Cow
CNBC View EBS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EBS - OTC Markets
Yahoo View Insider Transactions for EBS - Yahoo! Finance NASDAQ View Institutional Holdings for EBS - NASDAQ


Stock Charts

FinViz View EBS Stock Insight & Charts - FinViz.com StockCharts View EBS Investment Charts - StockCharts.com
BarChart View EBS Stock Overview & Charts - BarChart Trading View View EBS User Generated Charts - Trading View


Latest Financial News for EBS

Update in Lawsuit for Investors in NYSE: EBS Shares Against Emergent Biosolutions Inc. Announced by Shareholders Foundation
Posted on Monday February 12, 2018

SAN DIEGO, CA / ACCESSWIRE / February 12, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain purchasers of NYSE: EBS shares against Emergent Biosolutions Inc. over ...


See what the IHS Markit Score report has to say about Emergent Biosolutions Inc.
Posted on Thursday February 08, 2018

Emergent Biosolutions Inc NYSE:EBS


Emergent BioSolutions to Release Fourth Quarter and Full Year 2017 Financial Results and Conduct a Conference Call on February 22, 2018
Posted on Thursday February 08, 2018

GAITHERSBURG, Md., Feb. 08, 2018-- Emergent BioSolutions Inc. will host a conference call on Thursday, February 22, 2018 at 5:00 pm to discuss the financial results for the fourth quarter and full twelve ...


Here are the D.C.-area stocks getting pummeled in the market rout
Posted on Tuesday February 06, 2018

Nationally, among the biggest losers as of Monday was Seattle-based radio technology and software maker Impinj Inc. (PI), which saw its stock price plummet 45 percent to $11.94 between Jan. 29 and Feb. 5. The slide follows a stretch that saw U.S. stocks hit historic highs amid investor excitement over strong corporate earnings reports, a growing economy and the passage of a business-friendly tax bill. Last month, the stalwart Dow Jones Industrial Average took just seven days to add 1,000 points and surpass 26,000 for the first time in its history. Gina Martin Adams, chief equity strategist for Bloomberg Intelligence, said investors were overly optimistic in 2017 amid a steady stream of strong corporate earnings reports.


Emergent BioSolutions to Release Fourth Quarter and Full Year 2017 Financial ...
GlobeNewswire (press release) - Feb 8, 2018
GAITHERSBURG, Md., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 22, 2018 at 5:00 pm (Eastern Time) to discuss the financial results for the fourth quarter and full twelve ...
Emergent Biosolutions Inc (NYSE:EBS) Sentiment Up, Because - Frisco Fastball
California State Teachers Retirement System Sells 5334 Shares of Emergent ... - TrueBlueTribune

Why Emergent BioSolutions Inc. Jumped Higher Today
Motley Fool - Nov 3, 2017
Product sales increased 18% as Emergent BioSolutions delivered more of its botulism antitoxin, BAT, to the strategic national stockpile and shipped more RSDL, its skin decontamination and neutralization product, to the Department of Defense ...
Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q3 2017 Results - Earnings ... - Seeking Alpha
Emergent Biosolutions Shows Market Leadership With Jump To 93 RS Rating - Investor's Business Daily

Emergent BioSolutions: More Than An Emerging Biotech
Seeking Alpha - Nov 16, 2017
Emergent is an underrated $1.6-billion market cap biotech company that operates in the niche infectious disease market. Recent margin pressure has been noticeable.
Emergent Biosolutions (NYSE:EBS) Given New $53.00 Price Target at Chardan Capital - Dispatch Tribunal

Emergent BioSolutions: Expected Growth
Seeking Alpha - Sep 29, 2017
Emergent BioSolutions (NYSE:EBS) Inc. is a biopharmaceutical company which develops antibody therapeutics and vaccines for infectious diseases, autoimmune and oncology disorders.
Emergent BioSolutions Announces Closing of New $200 Million Senior Secured ... - GlobeNewswire (press release)
Emergent BioSolutions receives $25 million contract for intramuscular nerve ... - Homeland Preparedness News

Enter a stock symbol to view the stock details.